| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-05 |